Incretins
Journal of Endocrinology and Journal of Molecular Endocrinology have curated a collection of articles on incretins, led by Guest Editors Associate Professor Erin Mulvihill (University of Ottawa, Canada) and Dr Timo D Müller (Institute for Diabetes and Obesity (IDO), Germany).
This collection provides researchers with a comprehensive update on the latest developments in the field of Incretins through a series of invited reviews and recent research.
Published Articles:
The effects of GIP, GLP-1 and GLP-2 on markers of bone turnover: a review of the gut-bone axis
Miriam Longo, David Siersbaek Mathiesen, Laerke Gasberg, Katherine Esposito, Asger Bach Lund, and Filip K. Knop
Cardiovascular effects of tirzepatide
Priya Sumithran, Anthony W Russell, and Sophia Zoungas
Glucagon-like peptide-1 analog, liraglutide, regulates Sertoli cell energy metabolism
Marina Ercilia Dasso, Cecilia Lucia Centola, María Noel Galardo, Silvina Beatriz Meroni, and Maria Fernanda Riera
Incretin-mediated control of cardiac energy metabolism
Jordan S F Chan, Tanin Shafaati, and John R Ussher
GLP-1 receptor agonist-based and cardiovascular risk: a review of mechanisms
Neerav Mullur, Arianne Morissette, Nadya Morrow, and Erin Mulvhill
Gut hormone multi-agonists for the treatment of type 2 diabetes and obesity: advances and challenges
Xianxian Huang, Jing Liu, Guangquan Peng, Mingyue Lu, Zhongbo Zhou, Neng Jiang, and Zhiming Yan
Does GIPR blockade as well as agonism have a role to play in management of obesity and diabetes?
Ryan A. Lafferty, Peter R Flatt, Victor A Gault, and Nigel Irwin
Liraglutide alleviates experimental diabetic cardiomyopathy in a PDH dependent manner
Jordan Sf Chan, Amanda A Greenwell, Christina T Saed, Magnus J Stenlund, Indiresh A Mangra-Bala, Seyed Amirhossein Tabatabaei Dakhilli, Kunyan Yang, Sally R Ferrari, Farah Eaton, Keshav Gopal, and John R Ussher
The GLP-1R as a model for understanding and exploiting biased agonism in next-generation medicines
Jonathan D Douros, Jacek Mokrosinski, and Brian Finan
The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue
Samrin Kagdi, Sulayman Lyons, and Jacqueline L Beaudry
Glucagon resistance and metabolic-associated steatotic liver disease: a review of the evidence
Emma Rose McGlone, Steve R Bloom, and Tricia Mei-Mei Tan
Lipid regulation of the glucagon receptor family
Affiong Ika Oqua, Yusman Manchanda, Emma Rose McGlone, Ben Jones, Sarah Rouse, and Alejandra Tomas
The emerging role of glucagon-like peptide-1 in binge eating
Katherine N. Balantekin, Martin J. Kretz, and Elizabeth G Mietlicki-Baase
Cellular mechanisms of incretin hormone secretion
Marta Santos-Hernández, Frank Reimann, and Fiona M Gribble
Collection editors:
Associate Professor Erin Mulvihill
Department of Biochemistry, Microbiology and Immunology
Faculty of Medicine
University of Ottawa
Canada
Dr Timo D Müller
Acting Director and Head of Division of Molecular Pharmacology
Institute for Diabetes and Obesity (IDO)
Helmholtz Center Munich
Germany
